(dailyRx News) The U.S. Food and Drug Administration (FDA) approved the drug Invega to be prescribed to children. Invega is an anti-psychotic time release tablet that helps treat schizophrenia. Until now, Invega was only FDA approved to be prescribed to adults.
The effectiveness of Ivega for teens was done all over the world among twelve to seventeen year olds diagnosed with Schizophrenia. Participants were randomly given a placebo pill or a dosage of Invega for a six week trial basis. The participants and the effectiveness of the medication was evaluated at the end of the six weeks.
The study determined the appropriate dosage for children should be 3 to 12 milligrams of Invega. The FDA approval of Invega for children will help doctors imrpove the Schizophrenia treatment among kids.
Invega has been on the market since 2006. Inevga is run by Janssen Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.